StonvexLoading…
StonvexStonvexStonvexCore line items from DTCX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.18M | $6.96M | $551.00 | $166.00 |
Operating Income | $-5.02M | $-7.92M | $-13.99M | $-3.39M |
Net Income | $-6.15M | $-8.50M | $-13.78M | $-3.33M |
EPS (Diluted) | $-0.20 | $-0.46 | $-1.27 | $-0.35 |
Total Assets | $79.41M | $66.84M | $51.66M | $2.60M |
Total Liabilities | Not available | Not available | $882.70K | $781.27K |
Cash & Equivalents | $42.47M | $38.92M | $44.08M | $60.43K |
Free Cash Flow OCF − CapEx | Not available | $-32.39M | $-4.96M | Not available |
Shares Outstanding | 34.89M | 30.38M | 16.54M | 9.68M |